The ability of SRF to bypass the P-gp probably explains why it is more potent than taxol in the SH-SY5Y neuroblastoma and HCT-15 colorectal adenocarcinoma cells as both these cancer cell types express elevated levels of P-gp protein [17]–[19]. The gene discussed is PGP; the disease is cancer.